Form 13-F position report

TRILLIUM THERAPEUTICS INC

Reported by WELLS FARGO & COMPANY MN

CUSIP 89620X506 Manager CIK 0000072971

Reported 0 shares, down 4,620 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 26 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for TRILLIUM THERAPEUTICS INC held by WELLS FARGO & COMPANY MN.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2021 Reduced 0 -4,620 (-100.0%) 0 $0 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

175 managers reported TRILLIUM THERAPEUTICS INC for Q4 2021.

Managers reporting TRILLIUM THERAPEUTICS INC in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Optiver Holding B V Unchanged 1,049 0 < 0.01% $18,000 2 qtrs
Total Clarity Wealth Management Inc Reduced 0 -250 0 $0 4 qtrs
SG Americas Securities LLC Reduced 0 -96,664 0 $0 2 qtrs
GABELLI FUNDS LLC Reduced 0 -1,793,880 0 $0 5 qtrs
ProShare Advisors LLC Reduced 0 -12,741 0 $0 3 qtrs
STATE OF WISCONSIN INVESTMENT BOARD Reduced 0 -126,500 0 $0 3 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 0 -49,258 0 $0 2 qtrs
CREDIT SUISSE AG Reduced 0 -315,046 0 $0 5 qtrs
BlackRock Inc Reduced 0 -6,112,610 0 $0 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 0 -850,207 0 $0 15 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 14, 2022
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.